CG Oncology, Inc.
corporate_fare Company Profile
CG Oncology, Inc. (NASDAQ:CGON) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for CGON at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- CG Oncology Expands At-The-Market Offering by $300M to a Total of $550M, Signaling Significant Dilution
- CG Oncology Accelerates Phase 3 Bladder Cancer Trial Data Readout, Reports Strong Clinical Results
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.04M
Net Income
-$161M
Diluted EPS
-$2.08
Op. Cash Flow
-$132.35M
Free Cash Flow
-$132.48M
Gross Profit
-$607K
Operating Income
-$190.77M
Cash & Equivalents
$32.49M
Total Debt
$3M
Debt / Equity
0.00×
Net Margin
-39.85×
Shares Outstanding
80.69M sh
Source: 10-K · filed 2026-02-27 · accession 0001193125-26-079498
show_chartPrice Chart
Loading chart...